When you think of a pharmaceutical company, you may picture scientists and researchers in labs creating new or better medications to help tackle diseases. But there’s more.
Those scientists and researchers are only one part of the equation. After all, medication is of no use if it does not get to the people who need it.
Merck has a dedicated team of people who make these medicines, as well as package and distribute them to the people who need them. These employees, located all over the country, make our break-through inventions a reality.
Our manufacturing facilities, suppliers and partners comprise a global manufacturing network that is committed to delivering medicines and vaccines to customers and patients.
Merck has more employees in the U.S. than we have in any other country: 25,000 full-time employees in highly-skilled jobs that pay well and generate growth for the U.S. economy.
Since 2010, Merck has invested more than $60B into R&D, most of it in the U.S.
Merck is among the top investors in R&D, spending more than $7B in 2017 alone.
Bulk materials for all of Merck’s FDA-approved vaccines for people in the U.S. are made in the U.S.
In the past five years, Merck has invested ~$7.5 billion in capital projects, including nearly $5 billion in the U.S.
In 2016, Merck paid about $1.5B in total U.S. Employer and Employee taxes (including federal, state, local, and unemployment tax) with the Employer-only taxes equaling approx. $250M.
Home of our global headquarters since 1992. Merck has more than 6,500 employees in New Jersey, many of them researchers.
Merck employs more than 900 employees in Virginia, most at our manufacturing plant in Elkton, in Rockingham County.
Merck employs more than 13,100 people in Pennsylvania, with 3,000 in manufacturing and 3,000 in research.
Merck employs more than 1,400 employees in North Carolina, most at our manufacturing plants in Durham and Wilson counties.